These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8787884

  • 21. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.
    Garré B, Shebany K, Gryspeerdt A, Baert K, van der Meulen K, Nauwynck H, Deprez P, De Backer P, Croubels S.
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4308-14. PubMed ID: 17846132
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function.
    Smith JP, Weller S, Johnson B, Nicotera J, Luther JM, Haas DW.
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1146-51. PubMed ID: 20038622
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
    Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A.
    Lancet; 2012 Feb 18; 379(9816):641-7. PubMed ID: 22225814
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
    Kimberlin DF, Weller S, Whitley RJ, Andrews WW, Hauth JC, Lakeman F, Miller G.
    Am J Obstet Gynecol; 1998 Oct 18; 179(4):846-51. PubMed ID: 9790357
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy.
    Steingrimsdottir H, Gruber A, Palm C, Grimfors G, Kalin M, Eksborg S.
    Antimicrob Agents Chemother; 2000 Jan 18; 44(1):207-9. PubMed ID: 10602752
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
    Feinberg JE, Hurwitz S, Cooper D, Sattler FR, MacGregor RR, Powderly W, Holland GN, Griffiths PD, Pollard RB, Youle M, Gill MJ, Holland FJ, Power ME, Owens S, Coakley D, Fry J, Jacobson MA.
    J Infect Dis; 1998 Jan 18; 177(1):48-56. PubMed ID: 9419169
    [Abstract] [Full Text] [Related]

  • 34. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
    Smiley ML, Murray A, de Miranda P.
    Adv Exp Med Biol; 1996 Jan 18; 394():33-9. PubMed ID: 8815698
    [No Abstract] [Full Text] [Related]

  • 35. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K.
    Arch Intern Med; 1996 Jan 18; 156(15):1729-35. PubMed ID: 8694673
    [Abstract] [Full Text] [Related]

  • 36. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.
    Beutner KR.
    Antiviral Res; 1995 Dec 18; 28(4):281-90. PubMed ID: 8669888
    [Abstract] [Full Text] [Related]

  • 37. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM, Faulds D.
    Drugs; 1996 Nov 18; 52(5):754-72. PubMed ID: 9118821
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: can intravenous acyclovir be substituted by oral valacyclovir?
    Eksborg S, Pal N, Kalin M, Palm C, Söderhäll S.
    Med Pediatr Oncol; 2002 Apr 18; 38(4):240-6. PubMed ID: 11920787
    [Abstract] [Full Text] [Related]

  • 39. Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers.
    Pue MA, Pratt SK, Fairless AJ, Fowles S, Laroche J, Georgiou P, Prince W.
    J Antimicrob Chemother; 1994 Jan 18; 33(1):119-27. PubMed ID: 8157552
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.